Find News

Filter articles

Applied Filters

Showing 61 to 70 of 700 results

Roche buys fibrotic diseases biotech in $1.4bn deal

Switzerland, US19-11-2019

Switzerland-based Roche has agreed to acquire Promedior and its portfolio of molecules for serious fibrotic diseases. 

Merck and Evotec strike CRISPR licensing deal

Germany14-11-2019Rory O'Neill

Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.

EPO upholds validity of eye transplant patent

EU31-10-2019Rory O'Neill

Lawyers representing Italian medical devices company iVis Technologies have welcomed a decision of the European Patent Office to confirm the validity of one of the company’s patents, and are now pressing ahead with infringement claims against a German rival.

Pfizer: ‘Don’t be catfished by counterfeit drugs’

UK17-10-2019Rory O'Neill

Pfizer UK has launched a new social media campaign urging people not to be “catfished” into buying counterfeit drugs.

CMA alleges collusion allowed 1,800% hike in Aspen drug pricing

UK09-10-2019Sarah Morgan

African drugmaker Aspen was able to increase its prices for fludrocortisone acetate tablets by 1,800% in the UK, as a result of collusion with two other firms, according to the UK’s Competition and Markets Authority.

Sandoz secures victory against GSK in passing off case

UK08-10-2019Sarah Morgan

The English High Court has sided with pharmaceutical company Vectura and Novartis-owned Sandoz in a passing off lawsuit brought by rival GSK.

UK parliament report reveals threat to medical supplies post-Brexit

UK27-09-2019Rory O'Neill

An independent parliamentary report has today, September 27, revealed that the UK’s health ministry remains unsure whether the country’s health service can fully withstand the impact of a no-deal Brexit next month.

UK Labour promises public generics company, compulsory drug licensing

UK25-09-2019Rory O'Neill

Jeremy Corbyn, leader of the UK Labour Party, has pledged to create a publicly-owned drugs manufacturer and use compulsory licensing to sell generic, lower priced versions of drugs to the country’s National Health Service.

EU parliament challenges EPO on plant patentability

EU24-09-2019Rory O'Neill

The European Parliament has said that the internal rules of the European Patent Office “must not undermine democratic political control of European patent law”.

Oxford Nanopore signs CRISPR licence

UK20-09-2019Sarah Morgan

UK-based Oxford Nanopore has obtained a licence to CRISPR-Cas9 IP for nanopore sequencing, a third-generation approach used in the sequencing of biopolymers.

Showing 61 to 70 of 700 results